At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
Ambulatory ECGdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
In Brief
A clinical study evaluating Ambulatory ECG for Atrial Fibrillation and 2 related conditions. Completed, enrolled 17 participants across 1 site.
Detailed Summary
This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Arrhythmias, Cardiac, Atrial Flutter
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartDec 2018
Primary CompletionJul 2019
Study CompletionAug 2019
TodayJul 2026
First PostedDec 7, 2018
Enrollment StartDec 8, 2018
Primary CompletionJul 5, 2019
Study CompletionAug 20, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.6 years ago
Interventions
Ambulatory ECGdevice
Eligible participants are asked to wear the ambulatory ECG monitor